Loading articles...

Montreal-led clinical trial for potential treatment of COVID-19 symptoms

A health-care worker swabs a man at a walk-in COVID-19 test clinic in Montreal North, Sunday, May 10, 2020, as the COVID-19 pandemic continues in Canada and around the world. (THE CANADIAN PRESS/Graham Hughes)

MONTREAL (CITYNEWS) – A clinical trial led by the Montreal Heart Institute is studying the effectiveness of a drug commonly prescribed to treat gout and assessing whether it can be used to treat COVID-19 patients.

The COLCORONA clinical trial will be studying if the drug colchicine can prevent complications in non-hospitalized patients with the virus.

On Saturday, Quebec Premier Francois Legault invited Quebecers to take part in the study.

Researchers are looking for non-hospitalized patients who have been diagnosed with COVID-19 or have the symptoms associated with the virus to take part in the expanded clinical trial.